Abstract | PURPOSE: To evaluate the safety and efficacy of percutaneous aspiration and ethanol sclerotherapy as the sole treatment for symptomatic, nonneoplastic, congenital hepatic cysts. PATIENTS AND METHODS: RESULTS: Fifty-seven (97%) of 59 sclerotherapy procedures were technically successful, and there were no recurrences. Eight cysts in six patients disappeared totally. The mean diameter of the remaining 49 cysts decreased from 9 cm to 3 cm. At the last follow-up visit, 14 patients were asymptomatic, four had milder epigastric pain than before the treatment, and seven with polycystic liver disease had recurrent symptoms due to growth of nontreated cysts. No major complications occurred. CONCLUSION: Percutaneous aspiration with ethanol sclerotherapy is a safe, effective, and minimally invasive treatment method for symptomatic congenital cysts. It is the initial treatment of choice for all patients with symptomatic congenital hepatic cysts.
|
Authors | T Tikkakoski, J T Mäkelä, S Leinonen, M Päivänsalo, J Merikanto, A Karttunen, T Siniluoto, M I Kairaluoma |
Journal | Journal of vascular and interventional radiology : JVIR
(J Vasc Interv Radiol)
1996 Mar-Apr
Vol. 7
Issue 2
Pg. 235-9
ISSN: 1051-0443 [Print] United States |
PMID | 9007803
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Cysts
(congenital, diagnostic imaging, therapy)
- Drainage
(methods)
- Ethanol
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Liver Diseases
(congenital, diagnostic imaging, therapy)
- Male
- Middle Aged
- Prospective Studies
- Radiography
- Sclerotherapy
(methods)
- Time Factors
- Treatment Outcome
- Ultrasonography
|